Tech Company Inital Public Offerings
Akouos IPO
On 6/25/2020, Akouos completed its IPO
Transaction Overview
Company Name
Announced On
6/25/2020
Transaction Type
IPO
Amount
$212,500,000
Proceeds Purpose
We intend to use the net proceeds to us from this offering, together with our existing cash and cash equivalents, to advance clinical development of AK-OTOF for the treatment of OTOF-mediated hearing loss through the report of preliminary clinical data from our planned Phase 1/2 clinical trial; initiate clinical development of our additional product candidates, anti-VEGF, CLRN1, and GJB2; continue preclinical development of our other product candidates and development programs, including our autosomal dominant hearing disorder and our hair cell regeneration programs; establish internal manufacturing capabilities of 250-liter capacity; and for working capital and other general corporate purposes.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
645 Summer St. 200
Boston, MA 02210
USA
Boston, MA 02210
USA
Phone
Website
Email Address
Overview
Akouos (Nasdaq: AKUS) is developing targeted therapies to restore and preserve hearing in genetically-defined patient populations.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Emmanuel Simons
Chief Medical Officer
Michael McKenna
Chief Scientific Officer
Gregory Robinson
VP - Bus. Development
Morgan Molloy
VP - Bus. Development
Rabia Ozden
VP - Finance
Aninda Katragadda
VP - General Counsel
Karoline Shair
VP - Human Resources
Steve Burke
VP - Product Management
John Connelly
VP - Regulatory Affairs
Jennifer Wellman
Browse more venture capital transactions:
Prev: 6/25/2020: Landed venture capital transaction
Next: 6/25/2020: Calibrate venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs